Insiders Trades

★ Sign in to follow

JM

Jeffrey Mark Rowe

Shareholder

Zomedica Pharmaceuticals Corp.

Cumul. flow

Total declarations

16

Company

1

▲ Purchases (11 ops.)

€137k

▼ Sales (0 ops.)

—

Latest filing published 15 Dec 2018 for Zomedica Pharmaceuticals Corp., €16k.

Filing timeline

BuySale

Jeffrey Mark Rowe

Insider track record

Disclosed buys

11

Disclosed sells

0

Signal history

Jeffrey Mark Rowe: trading record in brief

Jeffrey Mark Rowe appears in our data through filings on Zomedica Pharmaceuticals Corp. shares, published by SEDI. In total, 16 filings cover trades dated from 21 April 2016 to 29 November 2018.

No open-market sale appears; the market trades are 11 purchases worth €137k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. So far in 2018, the count stands at 7 purchases and no sales.

In size, the median ticket on the buying side is €7,261. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

Most recently, on 15 December 2018, the filings show an option exercise worth €16k in Zomedica Pharmaceuticals Corp. The clock since the last published purchase (13 August 2018) now reads 2,994 days. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jeffrey Mark Rowe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Zomedica Pharmaceuticals Corp. (CA)

Declarations16 total

◇

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives23 Mar 2018Zomedica Pharmaceuticals Corp.

25,000 CAD12SEDI

100,000 shares@ CA$0.258.3% of flowCommon SharesTSXSEDI:3281696

◇

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives29 Nov 2018Zomedica Pharmaceuticals Corp.

262,500 CAD19SEDI

175,000 shares@ CA$1.5091.7% of flowCommon SharesTSXSEDI:3281699

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives21 Oct 2016Zomedica Pharmaceuticals Corp.

10,500 CAD0SEDI

10,000 shares@ CA$1.05Common SharesTSXSEDI:3221814

Canonical exit: 19 Jan 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives14 Nov 2016Zomedica Pharmaceuticals Corp.

11,000 CAD0SEDI

10,000 shares@ CA$1.10Common SharesTSXSEDI:3221822

Canonical exit: 12 Feb 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives27 Oct 2016Zomedica Pharmaceuticals Corp.

20,520 CAD0SEDI

19,000 shares@ CA$1.08Common SharesTSXSEDI:3221815

Canonical exit: 25 Jan 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives16 Nov 2016Zomedica Pharmaceuticals Corp.

9,504 CAD0SEDI

8,800 shares@ CA$1.08Common SharesTSXSEDI:3221829

Canonical exit: 14 Feb 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives9 Nov 2016Zomedica Pharmaceuticals Corp.

27,500 CAD0SEDI

25,000 shares@ CA$1.10Common SharesTSXSEDI:3221820

Canonical exit: 7 Feb 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives15 Nov 2016Zomedica Pharmaceuticals Corp.

65,400 CAD0SEDI

60,000 shares@ CA$1.09Common SharesTSXSEDI:3221826

Canonical exit: 13 Feb 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives11 Nov 2016Zomedica Pharmaceuticals Corp.

29,920 CAD0SEDI

27,200 shares@ CA$1.10Common SharesTSXSEDI:3221821

Canonical exit: 9 Feb 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives23 Aug 2017Zomedica Pharmaceuticals Corp.

9,650 CAD13SEDI

5,000 shares@ CA$1.930.8% of flowCommon SharesTSXSEDI:3052823

Canonical exit: 21 Nov 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives25 Aug 2017Zomedica Pharmaceuticals Corp.

2,808 CAD15SEDI

1,300 shares@ CA$2.160.2% of flowCommon SharesTSXSEDI:3052830

Canonical exit: 23 Nov 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives25 Aug 2017Zomedica Pharmaceuticals Corp.

3,655 CAD15SEDI

1,700 shares@ CA$2.150.3% of flowCommon SharesTSXSEDI:3052827

Canonical exit: 23 Nov 2017 (T+90)

▲

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives21 Aug 2017Zomedica Pharmaceuticals Corp.

9,150 CAD11SEDI

5,000 shares@ CA$1.830.7% of flowCommon SharesTSXSEDI:3052820

Canonical exit: 19 Nov 2017 (T+90)

●

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives28 Dec 2016Zomedica Pharmaceuticals Corp.

876,720 CAD18SEDI

584,480 shares@ CA$1.5074.9% of flowCommon SharesTSXSEDI:2934700

●

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives21 Apr 2016Zomedica Pharmaceuticals Corp.

0SEDI

Common SharesTSXSEDI:2829919

●

Jeffrey Mark Rowe

6 - Director or Senior Officer of 10% Security HolderExecutives21 Apr 2016Zomedica Pharmaceuticals Corp.

0SEDI

Common SharesTSXSEDI:2829958

16 of 16 declarations